Prelude Therapeutics Incorporated (PRLD) Stock Price & Financial Analysis
Prelude Therapeutics Incorporated Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Prelude Therapeutics Incorporated
What is the current stock price for PRLD?
As of the latest trading session, PRLD stock trades at $3.46. The 52-week range is $0.61–$4.22, with a day range of $3.27–$3.66.
What is the P/E ratio for PRLD?
The P/E ratio (Price-to-Earnings) for PRLD is shown in the Key Statistics section. This valuation metric helps compare Prelude Therapeutics Incorporated to industry peers.
Does PRLD pay dividends?
Prelude Therapeutics Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRLD?
Based on 1 analyst, the consensus for PRLD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PRLD?
Prelude Therapeutics Incorporated's market capitalization is $266.3M, classifying it as a micro-cap company. Prelude Therapeutics Incorporated operates in the Healthcare sector within the Biotechnology industry.